- Home
- TOVX vs MF Comparison
TOVX vs MF Comparison
Compare TOVX & MF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$0.22
N/A
Current Price
$9.25
Company Overview
Basic Information| Metric | TOVX | MF |
|---|---|---|
| Founded | 2001 | 2018 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.1M | 9.5M |
| IPO Year | 2012 | 2021 |
Fundamental Metrics
Financial Performance| Metric | TOVX | MF |
|---|---|---|
| Price | $0.22 | $9.25 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $2.50 | N/A |
| AVG Volume (30 Days) | ★ 363.9K | 73.5K |
| Earning Date | 08-11-2026 | 12-29-2022 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 89.07 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.16 | $5.07 |
| 52 Week High | $0.86 | $22.56 |
Technical Indicators
Market Signals| Indicator | TOVX | MF |
|---|---|---|
| Relative Strength Index (RSI) | 44.85 | 36.30 |
| Support Level | $0.17 | N/A |
| Resistance Level | $0.26 | $11.05 |
| Average True Range (ATR) | 0.01 | 2.01 |
| MACD | 0.00 | -0.62 |
| Stochastic Oscillator | 27.17 | 6.22 |
Price Performance
Historical Comparison TOVX
MF
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system. Product Candidates includes SYN-004 (ribaxamase) and SYN-020.